Flatiron Health
Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.
Flatiron Health remains the definitive real-world evidence partner for oncology, but its enterprise pricing narrows the audience. The addition of Flatiron Telescope and ML models shows real AI progress. Buyers should confirm whether self-service or full-service fits their needs.
Verified 4d ago · liveness 60/100 · cite: rightaichoice.com/tools/flatiron-health
- Life sciences companies generating real-world evidence for regulatory submissions
- Oncology researchers needing large-scale, high-fidelity patient data
- Biopharma firms using AI-driven insights for clinical trial design
- Healthcare providers seeking point-of-care tools with real-world data
- Early-stage startups with limited budget for enterprise data partnerships
- Researchers needing real-world data beyond oncology
- Teams requiring rapid, self-service analytics without vendor support
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Flatiron Health if you need free or self-serve access to real-world oncology data, if your research spans non-oncology indications, or if your team lacks the budget for enterprise contracts and vendor-managed analytics.
High contract minimums: expect six-figure annual commitments, with pricing negotiated per project and data access , which can surprise teams used to SaaS subscriptions.
Flatiron sits at the premium end of real-world evidence pricing, with contracts typically in the six figures annually. Compared to alternatives like TriNetX (which offers more flexible , lower-cost access) or Tempus (with self-serve options), Flatiron's cost is justified only if you need regulatory-grade, oncology-specific evidence with deep AI and publication support.
In short
Flatiron Health — Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care. Best for Life sciences companies generating real-world evidence for regulatory submissions, Oncology researchers needing large-scale, high-fidelity patient data, Biopharma firms using AI-driven insights for clinical trial design. Contact Sales pricing.
What's new in Flatiron Health
Checked 4 days agoAcross the latest 1 update: 1 feature update.
Viability Score
How well maintained and how widely used is Flatiron Health? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: September 2026
How we score →Key Features
- Flatiron Telescope AI platform for rapid insights
- LLM-based thematic analysis of clinical trial discussions
- ML models predicting rapid progression in HR+/HER2- mBC
- Real-world biomarker testing studies
- Regulatory-grade real-world evidence generation
- Global oncology patient data captured at source
- Multi-cancer type cohort identification
- Custom study design and analytics services
- Point-of-care clinical decision support
- EHR system integration
- Genomic sequencing integration
- Real-world outcomes analysis
- Publication support
- Data quality assurance
About Flatiron Health
Flatiron Health is an oncology-specific real-world evidence platform that captures high-fidelity data from millions of cancer patients globally, directly at the source, and transforms it into actionable insights for life sciences researchers and point-of-care clinicians. It answers oncology's toughest questions by learning from the experience of every person with cancer, combining high-quality data with AI that's powered by human expertise. The platform supports regulatory-grade real-world evidence generation, with over 2,000 peer-reviewed publications to date, covering a wide range of cancer types and clinical scenarios. Key capabilities include Flatiron Telescope, an AI platform that delivers insights in minutes; LLM-based thematic analysis of clinical trial discussions; ML models predicting rapid progression in HR+/HER2- metastatic breast cancer on frontline CDK 4/6 inhibitors; and real-world biomarker testing studies. At ASCO 2026, Flatiron presented 49+ research acceptances and showcased next-generation AI, further cementing its position at the forefront of oncology real-world data. The company's recent expansion into Scotland and partnership with Quest Diagnostics extend its network and test access, expanding the breadth of patient data and clinical insights available to researchers. Flatiron's global oncology engine enables multi-cancer type cohort identification, custom study design, and analytics services, along with data quality assurance and publication support. For life sciences companies needing validated evidence under regulatory scrutiny, Flatiron is the oncology-specific benchmark. Its enterprise focus and high cost limit accessibility for smaller organizations, but for mission-critical cancer research, the depth of data and AI integration is unmatched versus generic EHR data providers.
Behind the Verdict
Flatiron Health is the gold standard in oncology real-world evidence, but it is not for the faint of heart—or the small of budget. Here's the long view. **Strengths:** The platform's core value is its proprietary data: high-fidelity, at-source capture from millions of cancer patients, covering the full care continuum. That data fuels publications (2,000+ and counting) and regulatory-grade evidence, which is why life sciences companies rely on it for label expansions and post-market commitments. The AI layer—Flatiron Telescope, LLM-based thematic analysis, ML models for rapid progression—is directly applied to oncology questions, not generic. That specificity is a moat. For point-of-care, OncFlatiron brings treatment guidelines to clinicians in the workflow, improving decision quality. **Weaknesses:** It is expensive, B2B-only, and opaque. No self-service tier exists; you must engage with sales, commit to contracts, and likely spend six figures or more. Public documentation is minimal, so you cannot evaluate feasibility on your own. The platform is oncology-only, so multi-therapeutic teams need additional solutions. And despite the AI, it is still a partnership, not a plug-and-play SaaS. **Where it fits:** Large biopharma, research consortia, and regulatory agencies that need validated evidence and have the budget for dedicated vendor support. Also fits specialty clinics that want point-of-care support integrated with EHR. **Where it doesn't:** Startups needing lightweight insights, academic labs with limited funding, and any organization seeking self-serve RWD. If you need non-oncology data, you're out of luck. **Bottom line:** If your mission is to improve cancer care with real-world data and you have the resources, Flatiron is unmatched. If you're a smaller player, consider whether a cheaper, self-service RWD aggregator (like TriNetX or Tempus) could meet your needs—recognizing they may lack Flatiron's depth and regulatory pedigree.
Researching Flatiron Health? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Flatiron Health actually fits — and what changes day-one when you adopt it.
You need to quickly assess real-world treatment patterns for a new lung cancer drug and design a post-marketing study.
Outcome: Using Flatiron Telescope, you identify eligible patient cohorts across multiple cancer types within minutes, then work with Flatiron's team to design a custom study, leveraging their data quality and analytics services.
You want evidence-based treatment recommendations at the point of care, integrated with your EHR.
Outcome: You use Flatiron's point-of-care tool to access up-to-date guidelines and real-world outcomes, improving treatment decisions while staying in your clinical workflow.
You need real-world evidence to support a label expansion for an approved therapy.
Outcome: You leverage Flatiron's regulatory-grade evidence generation and publication support to produce the required analyses, expediting submission with data that has informed over 2,000 publications.
Use Cases
- Analyze real-world treatment patterns and outcomes for oncology patients.
- Generate regulatory-grade evidence for label expansion or post-marketing requirements.
- Provide clinicians with up-to-date treatment guidelines at the point of care.
- Assess study feasibility using Flatiron Telescope AI platform.
- Conduct LLM-based thematic analysis of clinical trial discussions.
- Identify patient cohorts across multiple cancer types for research.
- Perform real-world biomarker testing and outcomes studies.
- Support publication and submission for peer-reviewed journals.
Models Under the Hood
as of 2026-08-30
Limitations
- Flatiron Health is a B2B platform with no self-service or free tier, and access requires vendor partnerships, implying high cost and contract minimums.
- Product documentation is not public.
- The platform is oncology-specific, focusing on real-world evidence and point-of-care decisions, which may not suit multi-therapeutic research programs.
as of 2026-08-30
Verification history
We have re-verified Flatiron Health 17 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-checked, vendor evidence unchanged
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
Showing the 6 most recent of 17 verification passes.
Free to cite with attribution — this page re-verifies continuously.
Where the pricing makes sense
The company stage and team size where Flatiron Health's pricing actually pencils out — and where peers do it cheaper.
Flatiron sits at the premium end of real-world evidence pricing, with contracts typically in the six figures annually. Compared to alternatives like TriNetX (which offers more flexible , lower-cost access) or Tempus (with self-serve options), Flatiron's cost is justified only if you need regulatory-grade, oncology-specific evidence with deep AI and publication support.
Setup time & first value
How long it actually takes to get something useful out of Flatiron Health — broken out by persona, not the marketing-page minute.
For life sciences partners, initial data access and custom study design typically take 1–3 months, depending on scope and contracting. Point-of-care integration with EHRs may take several weeks to months, including IT setup and training.
Resources & Guides
Tutorials & Learning
![The Effects and Defects of Defaults // Lauren Ellsworth, Flatiron Health [FirstMark's Code Driven]](https://img.youtube.com/vi/prZG4iv7qBE/mqdefault.jpg)
Official links
Tools that pair well with Flatiron Health
Common stack mates teams adopt alongside Flatiron Health, with the specific reason each pairing earns its keep.
Alternatives to Flatiron Health
View allFrequently Asked Questions
Used Flatiron Health? Help shape our editorial sentiment research.